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Canola  oil  (Can)  and  hydrogenated  soybean  oil  (H2-Soy)  are  commonly  used  edible  oils.
However,  in  contrast  to soybean  oil  (Soy),  they  shorten  the survival  of stroke-prone  spon-
taneously  hypertensive  (SHRSP)  rats. It has  been  proposed  that  the  adverse  effects  of  these
oils on  the  kidney  and  testis  are caused  at  least  in  part by  dihydro-vitamin  K  (VK)  1 in  H2-Soy
and  unidentiﬁed  component(s)  in  Can.  Increased  intake  of  dihydro-VK1  is  associated  with
decreased  tissue  VK2  levels  and bone  mineral  density  in  rats  and humans,  respectively.  The
aim of  the present  study  was  to  determine  the  effects  of these  oils  on  bone  morphogenetic
protein  (BMP)-induced  ectopic  bone  formation,  which  is promoted  by  VK2  deﬁciency,  in
relation to the  role  of VK in  the -carboxylation  of  osteocalcin  and  matrix  Gla  protein.
A crude  extract  of  BMPs  was  implanted  into  a gap  in  the  fascia  of  the  femoral  muscle  in
5-week-old  mice  maintained  on  a Soy,  Can,  or H2-Soy  diet. Newly  formed  bone  volume,
assessed  by  three-dimensional  X-ray  micro-computed  tomography  and  three-dimensional056): Vitamin K3 (PubChem CID: 4055)
eywords:
reconstruction  imaging  for bone,  was  4-fold  greater  in  the  Can  and  H2-Soy  groups  than
in the Soy  group.  The  plasma  carboxylated  osteocalcin  (Gla-OC)  and  total  OC  (Gla-OC  plus
undercarboxylated  osteocalcin  [Glu-OC])  levels  were  signiﬁcantly  lower  in  the  Can  groupanola oilctopic calciﬁcation
ydrogenated soybean oil
atrix Gla protein
than in the  Soy  group  (p  < 0.05).  However,  these  levels  did  not  signiﬁcantly  differ  between
the H2-Soy  and  Soy  groups.  The  plasma  Gla-OC/Glu-OC  ratio  in  the  Can  and  H2-Soy  groups
was  signiﬁcantly  lower  (in Can; p = 0.044)  or  was  almost  signiﬁcantly  lower (in H2-Soy;
Abbreviations: BMP, bone morphogenetic protein; Can, canola oil; cMGP, carboxylated matrix Gla protein; dihydro-VK1, 2′ , 3′-dihydro-vitamin K1; Gla,
arboxyglutamic  acid; Gla-OC, carboxylated osteocalcin; Glu-OC, undercarboxylated osteocalcin; G6PDH, glucose-6-phosphate dehydrogenase; H2-Soy,
ydrogenated  soybean oil; mCT, micro-computed tomography; SHRSP rat, stroke-prone spontaneously hypertensive rat; Soy, soybean oil; TRI/3D-BON,
hree-dimensional reconstruction imaging for bone; ucMGP, undercarboxylated MGP; VK, vitamin K.
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Osteocalcin
Vitamin K
Bone  morphogenetic protein
p = 0.053)  than  that  in  the  Soy  group.  In conclusion,  Can  and  H2-Soy  accelerated  BMP-
induced  bone  formation  in  mice  to a greater  extent  than Soy.  Further  research  is required
to  evaluate  whether  the  difference  in accelerated  ectopic  bone  formation  is associated  with
altered  levels  of  VK2  and  VK-dependent  protein(s)  among  the  three  dietary  groups.
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1. Introduction
Canola oil (Can) and hydrogenated soybean oil (H2-Soy)
are  widely consumed by humans. However, the survival of
stroke-prone spontaneously hypertensive (SHRSP) rats is
signiﬁcantly  shortened when they are fed a diet containing
Can,  H2-Soy, high-oleic safﬂower oil, high-oleic sunﬂower
oil,  olive oil, or evening primrose oil compared to soybean
oil  (Soy), perilla oil, ﬂaxseed oil, ﬁsh oil, lard, or butter
fats [1–6]. A diet containing 10% Can increases blood pres-
sure  [7,8], decreases platelet counts [8], enhances blood
coagulation [9], increases hepatic glucose-6-phosphate
dehydrogenase (G6PDH, EC 1.1.1.49) activity [10], alters
Na+/K+ ATPase activity [7], decreases antioxidant enzyme
activity [10], increases plasma aldosterone levels while
decreasing plasma and testicular testosterone levels [11],
and  decreases the activities of antioxidant enzymes in red
blood  cells [6,12]. In 2000, a soybean phytosterol fraction
was  identiﬁed as a probable cause for the shortened sur-
vival  of SHRSP rats [13]. However, free fatty acid fractions
from Can containing similar amounts of phytosterols did
not  exhibit survival-shortening effects on SHRSP rats [14].
Therefore, we hypothesized that the presence of factor(s)
other than the fatty acids and phytosterols in these oils
might  affect the survival of SHRSP rats [5,14].
Vitamin K (VK) 1 is present in high concentrations in
vegetable oils, such as Soy and Can, and we believe that it
may  be one of the factors that affect the survival of SHRSP
rats.  VK1 contains one double bond at the phytyl side chain.
Upon  ingestion, the side chain of VK1 is removed enzymat-
ically  to form VK3, and then an isoprenyl side chain with
4  double bonds is attached to VK3 to form VK2 [15,16],
which has stronger physiological activities, including -
carboxylation of the Glu residues of osteocalcin (OC; bone
Gla  protein) and matrix Gla protein (MGP), than VK1 in
extrahepatic tissues [17,18]. During the industrial hydro-
genation of vegetable oils, the double bond in the side
chain of VK1 is hydrogenated to form dihydro-VK1, which
is  absorbed and delivered to various tissues [19], but is not
converted  to VK2 [20] (Fig. 1A). Moreover, dietary dihydro-
VK1  is reported to decrease tissue VK2 levels, resulting in
VK2  deﬁciency [19].
VK  is a cofactor for -glutamyl carboxylase, which cat-
alyzes the posttranslational modiﬁcation of VK-dependent
proteins such as coagulation factors (II, VII, IX, and X),
MGP,  and OC [21]. VK hydroquinone is the active form
of  VK (Fig. 1B) required for the synthesis of Gla proteins.
VK antagonists such as warfarin, which is a plant prod-
uct,  inhibit the carboxylation of VK-dependent proteins
by  inhibiting the synthesis of VK hydroquinone [22,23]
(Fig. 1B). Nicotinamide adenine dinucleotide phosphate
(NADPH) [24] required for the production of VK hydro-
quinone is supplied by G6PDH, which is a cytosolic enzymeished  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under
D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
in  the pentose phosphate pathway of glucose metabolism.
Thus, G6PDH activity might serve as a potential indicator
of  VK hydroquinone production.
MGP is a 14-kDa extracellular matrix protein syn-
thesized by chondrocytes, vascular smooth muscle cells,
endothelial cells, and ﬁbroblasts in the heart, lung, kid-
ney,  skin, and arterial vessel walls [25]. MGP  undergoes
two  types of posttranslational modiﬁcations – glutamate
carboxylation and serine phosphorylation [25] – and
potently inhibits arterial calciﬁcation [26–28] (Fig. 1C).
MGP-deﬁcient mice die within 2 months of birth because
of  extensive arterial calciﬁcation leading to blood vessel
rupture [27]. MGP  modulates the activity of bone morpho-
genetic protein (BMP; Fig. 1C), which induces osteogenesis
in  soft as well as in hard tissues [29–31].
Similar to MGP, OC is a calcium-binding protein
involved in bone metabolism, and it is carboxylated on
its  glutamate residues (Fig. 1C). OC-deﬁcient mice exhibit
increased bone formation [32]. Gla-OC plays an important
role in preventing bone hyperplasia (Fig. 1C).
VK plays a key role in the synthesis of both MGP  and
OC.  Undercarboxylated MGP  (ucMGP) and OC (Glu-OC)
are indirect markers of VK2 deﬁciency [34]. Speciﬁcally,
the plasma level of ucMGP is an indicator of vascular cal-
ciﬁcation [35]. However, a previous study reported that
a  phosphorylated MGP3-15 peptide lacking Gla residues
inhibited calciﬁcation [36]. Therefore, the role of VK in
the  regulation of the anticalciﬁcation activity of MGP  has
remained controversial.
Plasma  dephospho-ucMGP is a marker of vascular calci-
ﬁcation in chronic kidney disease [37,38] and is associated
with low VK levels [38–40]. Thus, VK deﬁciency accelerates
calciﬁcation and inhibits coagulation [28], and optimal VK
intake  is important in order to reduce the risk of occurrence
of  these diseases [28].
In  this study, the effects of Soy and Can (rich in VK1)
and H2-Soy (rich in dihydro-VK1) on BMP-induced ectopic
bone  formation were examined in relation to the role of VK
in  the -carboxylation of OC and MGP.
2. Materials and methods
2.1.  Chemicals
All  reagents were of analytical grade or higher qual-
ity and were purchased from commercial suppliers. Ethyl
esters  of linoleic and -linolenic acids, VK1, VK2, and VK3
were  purchased from Wako Pure Chemicals (Osaka, Japan),
and  dihydro-VK1 was  synthesized according to a published
method [41]. Soy and Can (rapeseed oil) were purchased
at a local market, and H2-Soy for human consumption
was  obtained from Hamari Chemicals Ltd. (Osaka, Japan).
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Fig. 1. Conversion of vitamin K (VK) 1 to VK2, production of dihydro-VK1, the VK cycle, and -glutamyl carboxylation. (A) VK1, but not dihydro-VK1, is
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orm  of VK (VK hydroquinone) is synthesized by the reduction of VK quin
roteins  by -glutamyl carboxylase via a VK hydroquinone-dependent sy
orcine cortical bones were purchased from a slaughter-
ouse.
.2. Animals and diets
The  basal diet consisted of AIN-93G without added Soy
nd  VK1 (Funabashi Farm Co., Ltd., Chiba, Japan). The Soy
nd  Can diets were prepared by mixing the basal diet and
he  appropriate oil at a ratio of 93:7. To prevent essential
atty acid deﬁciency in the mice on the H2-Soy diet, H2-Soy
nd  essential linoleic and -linolenic acids were added to
he  basal diet at ﬁnal concentrations of 5.2%, 0.9%, and 0.9%,
espectively. Dietary oils are the sole sources of VK1. The
iets  were pulverized and stored at −30 ◦C under hermetic
onditions and were used within 3 months of preparation.
he Soy diet was used as a control because it does not sig-
iﬁcantly shorten the survival of SHRSP rats [2–5]. The food
rovided  to the animals was replaced daily.
Male ddY mice (4 weeks old) were obtained from Japan
LC,  Inc. (Hamamatsu, Japan) and were randomly assigned
o  one of three groups (n = 6 per group). Mice in each group
ere  housed in the same cage under a 12/12 h light–dark
ycle at 23 ◦C and were fed a diet containing Soy, Can, or
2-Soy throughout the experiment. The study protocol was
pproved  by the Ethics Committee of Aichi-Gakuin Univer-
ity,  School of Dentistry (ethical clearance number: AGUD
57).
.3.  Determination of the dihydro-VK1 content of Soy,
an,  and H2-Soy
VK  homologues were extracted from the oils as fol-
ows: the oil (75 L) was mixed vigorously with methanolo dihydro-VK1 by the partial hydrogenation process [33]. (B) The active
1, VK2, and dihydro-VK1) [20]. (C) Gla proteins are synthesized from Glu
pathway.
(5  mL)  for 5 min, and VK homologues were separated by
centrifugation at 2000 rpm for 5 min  and quantiﬁed as
described previously [42]. Brieﬂy, high performance liquid
chromatography (HPLC) was  performed by injecting 50 L
of  the sample extract into the column (Nucleosil 100-5C18,
4.6  mm × 150 mm;  GL Science, Tokyo, Japan). The sample
was eluted with 100% methanol at a ﬂow rate of 1 mL/min at
room  temperature. The efﬂuent was  fed directly into a post-
column  reduction system (Platinum-Black Column RC-10,
4.0  mm × 30 mm;  Shiseido, Tokyo, Japan) with an applied
potential of −400 mV  to reduce the homologues, which
were detected using ﬂuorescence spectrophotometry (FS-
8020;  Tosoh, Tokyo, Japan) at excitation and emission
wavelengths of 320 and 430 nm,  respectively. The concen-
tration of the VK homologue was measured using the peak
area  method and calculated from a calibration curve.
2.4. Analysis of BMP-induced ectopic bone formation
using three-dimensional X-ray micro-computed
tomography (3D R mCT) and three-dimensional
reconstruction imaging for bone system (TRI/3D-BON)
A crude extract of BMPs was  prepared by freezing and
pulverizing fresh porcine cortical bone. The pulverized
bone was then demineralized with 0.6 M HCl for 72 h. The
preparation was washed with 2 M CaCl2 and then with
0.5  M EDTA, and was extracted with a buffer (6 M urea,
0.5  M CaCl2, 1 mM N-ethylmaleimide, and 1 mM benzami-
dine HCl) [29]. This crude extract of BMPs was used to
induce ectopic bone formation in the mice. The mice were
anesthetized with isoﬂurane (Abbott Japan Co., Ltd., Tokyo,
Japan)  after 1 week of acclimatization, during which they
were  fed the Soy, Can, or H2-Soy diet; a capsule containing
cology R
Induction of bone formation was  assessed 3 weeks after
the  crude extract of BMPs was implanted in the mice. The
total  amount of newly formed bone mass in the Soy group
was  approximately 25% that in the Can and H2-Soy groups
Fig. 2. Determination of the ratio of vitamin K (VK) 1 and dihydro-VK1 in
the  vegetable oils. (A) High performance liquid chromatography (HPLC)958 Y. Hashimoto et al. / Toxi
5 mg  of the crude extract of BMPs in #5 gelatin (Dainip-
pon Sumitomo Pharmaceuticals Co., Ltd., Osaka, Japan) was
implanted  into a gap in the fascia of the right femoral
muscle. Ectopic formation of new bone was visualized by
scanning  with a 3D R mCT  apparatus (Rigaku, Co., Tokyo,
Japan) 3 weeks after the operation. The amount of bone
was  measured using a TRI/3D-BON system (Ratoc System
Engineering Co., Ltd., Tokyo, Japan) [43].
2.5. Collection of blood and tissue samples
Mice (age, 9 weeks) were anesthetized with sevoﬂurane
(Mylan Pharmaceuticals, Mylan Inc., Osaka, Japan) and then
euthanized  by cardiac puncture. Blood was collected in a
tube  containing 10 L of 0.5 M ethylenediaminetetraace-
tic acid (EDTA) in phosphate-buffered saline (pH 7.2). The
plasma  was separated by centrifugation at 3000 rpm for
15  min  at 4 ◦C and stored at −80 ◦C. The heart, liver, kidneys,
and testes were removed and weighed. The liver sample
was  stored at −80 ◦C.
2.6.  Determination of G6PDH activity and total
antioxidant power in the liver
G6PDH activity was measured using a G6PDH assay
kit  (colorimetric; ab102529) purchased from Abcam (Lon-
don,  UK). Total antioxidant power was measured using a
total  antioxidant power kit (TA02) purchased from Oxford
biomedical research (Oxford, MI). Both values were mea-
sured  according to the manufacturers’ protocols. Brieﬂy,
10  mg  liver samples were homogenized in 0.3 mL  of
phosphate-buffered saline (pH 7.2), and the supernatants
(obtained upon centrifugation at 3000 × g for 12 min  at 4 ◦C
or  15,000 × g for 10 min  at 4 ◦C) were used to measure the
total  antioxidant power or G6PDH activity, respectively.
The protein concentration of the supernatants was  deter-
mined  using the method described by Hartree [44]. Bovine
serum  albumin (Sigma–Aldrich Co., St. Louis, MO)  was used
as  the standard.
2.7.  Determination of cMGP, Gla-OC, and Glu-OC levels
in  plasma
Plasma levels of cMGP, Gla-OC, and Glu-OC were mea-
sured  using enzyme-linked immunosorbent assay (ELISA)
kits.  The CBS-E16540m (Cusabio Biotech Co., Ltd., Hubei,
China) and SEB477Mu (Cloud-Clone Corp., Houston, TX,
USA)  ELISA kits were used to estimate plasma levels of
mouse  cMGP. Mouse Gla-OC and Glu-OC High-Sensitivity
Enzyme Immunoassay Kits (MK127 and MK129, respec-
tively) were purchased from Takara Bio Inc. (Shiga, Japan).
2.8.  Statistical analysis
Data  are presented as means ± standard errors (SEs).
Mean differences were evaluated using one-way analysis of
variance  (ANOVA) followed by Tukey’s multiple compari-
son  tests using Excel SSR1 2012 for Windows (Social Survey
Research Co., Ltd., Tokyo, Japan). Mean differences with
respect  to the total amount of newly formed bone mass
induced by BMP  implantation and Gla-OC/Glu-OC ratioseports 1 (2014) 955–962
were  evaluated by one-way ANOVA followed by Dunnett’s
test  (with the Soy group used as the target). Values of
p  < 0.05 were considered statistically signiﬁcant.
3. Results
3.1. VK1 is present in the hydrogenated form in H2-Soy
All three oils contained VK1, but dihydro-VK1 was
detected only in H2-Soy (Fig. 2). Ninety-seven percent
of  VK1 was  hydrogenated during the hydrogenation pro-
cess  of Soy. The VK1 content of Soy, Can, and H2-Soy was
0.193  mg%, 0.127 mg%, and 0.006 mg%, respectively. The
dihydro-VK1 content of H2-Soy was 0.187 mg%. The total
VK  content in all three diets exceeded the present recom-
mended dietary allowance for humans [45].
3.2. Ectopic bone formation is enhanced by the Can and
H2-Soy dietsanalysis of the standard (Std; 5 ng each) and VK homologues eluted from
soybean oil (Soy), hydrogenated soybean oil (H2-Soy), and canola oil (Can).
The  VK1 and dihydro-VK1 content of H2-Soy was estimated from the
ratio of peak areas of VK1 and dihydro-VK1 in the H2-Soy eluted from
the column. (B) Exploded view of (A) after 10 min.
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Fig. 3. Newly formed bone in mice fed the soybean oil (Soy), canola oil (Can), or hydrogenated soybean oil (H2-Soy) diet after implantation with a
crude  extract of bone morphogenetic proteins (BMPs). (A) Representative reconstructed images generated from three-dimensional X-ray micro-computed
tomography  (3D R mCT) scans of ectopic newly formed bone (arrow) in the femoral muscle. (B) The volume of newly formed ectopic bone induced by
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p < 0.05 vs. Soy.
Fig. 3); thus, the Can and H2-Soy diets increased bone for-
ation  by approximately 4-fold.
.3. H2-Soy consumption increases the weights of the
estis, kidney, and liver
There  were no signiﬁcant differences in the wet weights
f  the body or heart among the groups (Table 1). However,
he  testis weight was signiﬁcantly greater (by factors of
.35  and 1.29) in the H2-Soy group than in the Soy and Can
roups,  respectively, whereas the liver and kidney weights
ere  signiﬁcantly higher in the H2-Soy group than in the
an  and Soy groups, respectively. No signiﬁcant differences
n  the body and tissue weights were detected between the
oy  and Can groups..4.  Hepatic G6PDH activity and total antioxidant power
As  shown in Table 2, the H2-Soy group had the high-
st hepatic G6PDH activity and total antioxidant power
able 1
issue weights of mice fed the soybean oil (Soy), canola oil (Can), and
ydrogenated soybean oil (H2-Soy) diets.a
Weight (g) Soy Can H2-Soy
Body 40.2 ± 0.8 40.2 ± 0.7 42.8 ± 1.5
Heart 0.18 ± 0.003 0.18 ± 0.003 0.19 ± 0.007
Liver 1.87 ± 0.10 1.65 ± 0.06** 2.09 ± 0.10
Kidney 0.58 ± 0.02* 0.61 ± 0.03 0.67 ± 0.02
Testis 0.20 ± 0.01* 0.21 ± 0.02* 0.27 ± 0.01
a Values are represented as mean ± standard error (SE) (n = 6 per group).
* p < 0.05 vs. H2-Soy.
** p < 0.01 vs. H2-Soy.Soy diets was  calculated from 3D R mCT  scans using three-dimensional
among the 3 dietary groups. G6PDH activity was signiﬁ-
cantly higher (p < 0.05) in the H2-Soy group than in the Soy
and  Can groups. In addition, the total antioxidant power
was  signiﬁcantly higher (p < 0.01) in the H2-Soy group than
in  the Can group. No signiﬁcant differences were detected
between the Soy and Can groups. G6PDH is known to sup-
ply  NADPH for the activity of reductases [24], which is
required for VK hydroquinone synthesis. The total antiox-
idant  power estimated in this study included the activities
of  reductases such as superoxide dismutase, catalase, and
glutathione peroxidase. These results suggest that, com-
pared  to the Soy diet, the Can and H2-Soy diets did not
inhibit the production of VK hydroquinone.
3.5. Plasma Gla-OC level, Gla-OC/Glu-OC ratio, and totalThe cMGP levels, measured using two different ELISA
kits, were not signiﬁcantly different, and no signiﬁcant
Table 2
Hepatic glucose-6-phosphate dehydrogenase (G6PDH) activity and total
antioxidant power in mice fed the soybean oil (Soy), canola oil (Can), and
hydrogenated soybean oil (H2-Soy) diets.a
Soy Can H2-Soy
G6PDHb 2.10 ± 0.11* 2.09 ± 0.09* 2.47 ± 0.11
TAOPc 57.8 ± 3.92 55.6 ± 0.85** 65.7 ± 2.94
a Values are represented as mean ± SE of duplicate assays (n = 6 per
group).
b G6PDH: glucose-6-phosphate dehydrogenase (mU/mg protein).
c TAOP: total antioxidant power (uric acid equivalent; pmole/mg pro-
tein).
* p < 0.05 vs. H2-Soy.
** p < 0.01 vs. H2-Soy.
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Table 3
Plasma levels of VK-dependent proteins (cMGP, OC, and OC derivatives) in
mice  fed the soybean oil (Soy), canola oil (Can), and hydrogenated soybean
oil (H2-Soy) diets.a
Soy Can H2-Soy
cMGP (ng/mL)b 113.0 ± 4.9 114.9 ± 3.6 110.9 ± 4.9
cMGP (ng/mL)c 88.6 ± 11.2 101.3  ± 18.4 78.7  ± 12.0
Gla-OC (ng/mL) 89.3 ± 7.9 59.0 ± 7.6* 73.8 ± 8.0
Glu-OC (ng/mL) 7.00 ± 0.81 6.55 ± 0.64 7.83 ± 0.82
Total OC (ng/mL)d 96.3 ± 8.0 65.5 ± 7.6* 81.6 ± 8.5
Gla-OC/total OC 0.93 ± 0.01 0.89 ± 0.01 0.90 ± 0.01
Gla-OC/Glu-OC 13.8 ± 1.96 9.4 ± 1.34*,** 9.6 ± 0.73***
cMGP, carboxylated MGP; Gla-OC, carboxylated osteocalcin; Glu-OC,
undercarboxylated osteocalcin; OC, osteocalcin.
a Values are represented as mean ± SE of duplicate assays (n = 6 per
group).
b Measured using a CBS-E16540m kit (Cusabio Biotech Co., Ltd., Hubei,
China).
c Measured using a SEB477Mu kit (Cloud-Clone Corp., Houston, TX,
USA).
d Total OC represents the combined levels of Gla-OC and Glu-OC.
* p < 0.05 vs. Soy.
** p = 0.044 vs. Soy.
*** p = 0.053 vs. Soy.
differences were detected in the plasma cMGP levels
among the three experimental groups (Table 3). The Gla-
OC  and the total OC (Gla-OC plus Glu-OC) levels were
the  lowest in the Can group among the 3 dietary groups;
these levels were signiﬁcantly lower in the Can group than
in  the Soy group. These levels were lower in the H2-Soy
group than in the Soy group, although the differences did
not  reach statistically signiﬁcant levels. The Gla-OC/Glu-OC
ratio of the Can group was signiﬁcantly lower than that of
the  Soy group (p = 0.044), and the ratio of the H2-Soy group
was  almost signiﬁcantly lower than that of the Soy group
(p  = 0.053).
4. Discussion
Newly formed bone mass induced by the implantation
of the crude extract of BMPs was greater by a factor of 4 in
the  Can and H2-Soy groups than in the Soy group (Fig. 3).
Plasma  calcium ion levels in the three groups were not
measured in the present study because no variations were
anticipated [9]. Moreover, the plasma Gla-OC and total OC
levels  were signiﬁcantly lower in the Can group than in the
Soy  group (Table 3). The lower Gla-OC/Glu-OC ratio in the
Can  and H2-Soy groups compared with the Soy group sug-
gests  the presence of differences in VK cofactor activities
among the dietary groups (Table 3). The Can diet signif-
icantly suppressed the production of total OC compared
with the Soy diet (p < 0.05; Table 3). The Gla-OC and total
OC  levels in the Can group were 66% and 68% of those in the
Soy  group, respectively. The low level of Gla-OC in the Can
group  may  be attributed partially to the low level of total
OC.  In addition, it has been reported that OC is important for
glucose  and lipid metabolisms as well as bone metabolism
[46]. Reduced total OC levels in the serum are associated
with metabolic syndrome [47], the severity of coronary
artery disease, and the risk of coronary heart disease in
Chinese  adults [46].
Although  MGP  is known to play a role in tissue calci-
ﬁcation, no signiﬁcant differences were observed in theeports 1 (2014) 955–962
cMGP  levels among the dietary groups (Table 3). This may
be  because the levels of cMGP were insufﬁcient to inhibit
ectopic bone formation, or there might have been differ-
ences  in the phosphorylation level of cMGP, which could
not  be estimated accurately by the methods used in the
current study. In another experiment that used miniature
pigs, we found that a 10 w/w%  Can diet suppressed the
mRNA level of MGP  by a factor of 0.66 compared with a
10  w/w% Soy diet, as assessed by DNA microarray analysis
(Miyazawa et al., manuscript in preparation). Therefore, the
Can  diet might suppress the expression of MGP  mRNA in
mice  as well.
The  volume of ectopic bone formation induced by the
implantation of the crude extract of BMPs was  similar
between the Can and H2-Soy groups (Fig. 3). However, sig-
niﬁcant  differences were detected in the liver and testis
weights (Table 1), hepatic total antioxidant power, and
G6PDH  activity between the two groups (Table 2). These
results suggest that the mechanism underlying the accel-
erated  bone formation might be different in the two  groups.
In  the H2-Soy group, 97% of VK1 was present as dihydro-
VK1 (Fig. 2). In dihydro-VK1, the single 2′, 3′ double
bond in the side chain is saturated and the naphtho-
quinone ring, which is the active site for the carboxylation
reaction, is unaltered. This inﬂuences the function of VK-
dependent proteins [33]. In rats, dihydro-VK1 is reported
to  be absorbed efﬁciently, and its biological activity is simi-
lar  to that of VK1 [20]. In contrast, the intestinal absorption
and biological activity of dihydro-VK1 are reported to be
lower  than those of VK1 in humans [33]. The present study
suggests that this cofactor activity of VK was slightly lower
in  the Can and H2-Soy groups than that in the Soy group.
In  the case of the H2-Soy diet, this lower activity may  be
attributed to dihydro-VK1, because (i) dihydro-VK1 is not
converted  to VK2 [20], (ii) the cofactor activity of VK2 is
stronger than that of VK1 in extrahepatic tissues [17,18],
and  (iii) intake of dihydro-VK1 reduces tissue VK2 lev-
els  [48]. In the Can diet, the VK1 content matched dietary
requirements; however, the Gla-OC level in this group was
the  lowest among the three groups. This may  be attributed
to  the low level of total OC in this group.
VK2 plays important roles in bone homeostasis related
to  gene transcription through steroid and xenobiotic recep-
tor  (SXR; an orphan nuclear receptor) activation [49,50],
and  in testosterone production in the testis [51,52].
Dihydro-VK1 is crucial for bone homeostasis and testos-
terone production, because it does not serve as a ligand for
SXR  and is not converted to VK2 [20], as mentioned above.
Suppression of osteocalcin production by the Can diet is
crucial  for not only glucose, lipid, and bone metabolisms
[46] but also steroid hormone metabolism [53]. Osteocalcin
promotes testosterone biosynthesis in the mouse testis and
modulates  reproductive function in humans [53]. A previ-
ous  study showed that serum and testis testosterone levels
were  lower in SHRSP rats on the Can and H2-Soy diets than
in  SHRSP rats on the Soy diet [11]. This is in agreement with
our  results. The increased weight of the testis in the H2-Soy
group  might be due to hyperplasia caused by decreased
testosterone levels.
In  this context, it is important to note that warfarin, a VK
antagonist, is widely used to treat individuals with a high
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isk of developing thrombosis. The 4-hydroxycoumarins
e.g., warfarin, acenocoumarol, and phenprocoumon) bind
o  VK reductases and inhibit VK recycling [22,23]. The
nsuing inhibition of the carboxylation of coagulation fac-
ors  results in the formation of inactive non-carboxylated
pecies (including ucMGP and Glu-OC). Blood clotting
actors require lower levels of VK for complete -
arboxylation in the hepatic tissues, whereas higher levels
re  required for -carboxylation of MGP  and OC in the
xtrahepatic tissues [34]. Patients who have atrial ﬁbril-
ation  and use VK antagonists exhibit increased levels of
oronary  calciﬁcation despite a low vascular risk [54].
oreover, warfarin use is associated with increased miner-
lization  of arterial blood vessels and cardiac valves as well
s  inactivation of MGP  and subsequent vascular calciﬁca-
ion  in rats [55]. Long-term use of coumarins is associated
ith enhanced extracoronary vascular calciﬁcation, pos-
ibly  through the inhibition of MGP  carboxylation [56]
Fig.  1C). Thus, the present data suggest that if patients
sing VK antagonists such as warfarin routinely consume
an  or H2-Soy, they may  be at an increased risk of calciﬁca-
ion  in their arterial blood vessels and cardiac valves. Our
esults  suggest that the underlying mechanisms responsi-
le  for these effects of Can and H2-Soy might be different.
hey also indicate that these mechanisms might be differ-
nt  from that underlying warfarin-induced calciﬁcation.
.  Conclusion
Our studies revealed that dietary Can and H2-Soy
nhanced BMP-induced ectopic bone formation by about
-fold  compared with dietary Soy in mouse models. Possi-
le  differences in the levels of VK2 status in the H2-Soy
roup and the suppressed levels of VK-dependent Gla
rotein(s) in the Can group might explain the differ-
nces observed in ectopic bone formation among the three
ietary  groups. However, further research is required to
xplain  the increase in bone formation by Can and H2-
oy  and to understand their potential role in cardiac valve
alciﬁcation and arteriosclerosis.
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